Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Head and/or Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01164566
What this trial is testing

Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy

Who this might be right for
Stage I Adenoid Cystic Carcinoma of the Oral CavityStage I Mucoepidermoid Carcinoma of the Oral CavityStage I Squamous Cell Carcinoma of the Hypopharynx+25 more
Wake Forest University Health Sciences 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07783581
What this trial is testing

Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial

Who this might be right for
Locally Advanced Oral Cavity Squamous Cell CarcinomaLocally Recurrent Oral Cavity Squamous Cell CarcinomaOral Cavity Squamous Cell Carcinoma
Mayo Clinic 30
Large-scale testing (Phase 3)Ended earlyNCT06790966
What this trial is testing

Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck CancerMetastatic Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+2 more
PDS Biotechnology Corp. 12
Early research (Phase 1)Study completedNCT04319757
What this trial is testing

ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic CancerSolid Tumor+2 more
Acepodia Biotech, Inc. 12
Not applicableEnded earlyNCT05003856
What this trial is testing

Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule

Who this might be right for
Benign Thyroid Gland NeoplasmRecurrent Thyroid Gland CarcinomaThyroid Gland Follicular Tumor of Uncertain Malignant Potential+2 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00537095
What this trial is testing

Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Genzyme, a Sanofi Company 164
Large-scale testing (Phase 3)WithdrawnNCT06513884
What this trial is testing

HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma Recurrent
Hookipa Biotech GmbH
Early research (Phase 1)Study completedNCT00675233
What this trial is testing

Photodynamic Therapy Using HPPH in Treating Patients With Dysplasia, Cancer in Situ, or Invasive Cancer of the Larynx

Who this might be right for
Head and Neck Cancer
Roswell Park Cancer Institute 29
Testing effectiveness (Phase 2)Looking for participantsNCT07410676
What this trial is testing

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Who this might be right for
CancerSarcomaLeukaemia+12 more
Essen Biotech 83
Large-scale testing (Phase 3)UnknownNCT00002747
What this trial is testing

Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer

Who this might be right for
Head and Neck Cancer
European Institute of Oncology 240
Testing effectiveness (Phase 2)Ended earlyNCT03246685
What this trial is testing

Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv SCCHN Who Failed Pembro Monotherapy or Experiencing SD

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
HiberCell, Inc. 1
Not applicableStudy completedNCT00973947
What this trial is testing

Customized Headrest or Standard Headrest in Holding Patients Still While Undergoing Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Cancer Trials Ireland 40
Testing effectiveness (Phase 2)Study completedNCT00118248
What this trial is testing

Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Recurrent Thyroid CancerStage IV Follicular Thyroid CancerStage IV Papillary Thyroid Cancer+1 more
National Cancer Institute (NCI) 41
Early research (Phase 1)WithdrawnNCT00328887
What this trial is testing

Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma

Who this might be right for
Esophageal Neoplasms
Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Study completedNCT00095563
What this trial is testing

Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers

Who this might be right for
High-grade Salivary Gland CarcinomaHigh-grade Salivary Gland Mucoepidermoid CarcinomaLow-grade Salivary Gland Carcinoma+7 more
National Cancer Institute (NCI) 40
Not applicableUnknownNCT01946867
What this trial is testing

NBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or Oropharynx

Who this might be right for
Head and Neck Cancer
Nanobiotix 75
Not applicableActive Not RecruitingNCT01660984
What this trial is testing

Natural History Study of Children and Adults With Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer
National Cancer Institute (NCI) 105
Early research (Phase 1)Active Not RecruitingNCT04603287
What this trial is testing

SI-B001, an EGFR/HER3 Bispecific Antibody, in Locally Advanced or Metastatic Epithelial Tumors

Who this might be right for
Locally Advanced or Metastatic Epithelial Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 60
Not applicableStudy completedNCT04603248
What this trial is testing

Identification of Immune Determinants for Response to Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Yonsei University 50
Testing effectiveness (Phase 2)Ended earlyNCT03740100
What this trial is testing

Single-arm Study With Bimiralisib in Patients With HNSCC Harboring NOTCH1 Loss of Function Mutations

Who this might be right for
HNSCC
M.D. Anderson Cancer Center 8
Next Page